Evidence map›Paper›PMID 29880489›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2018

Systemic Upregulation of IL-10 (Interleukin-10) Using a Nonimmunogenic Vector Reduces Growth and Rate of Dissecting Abdominal Aortic Aneurysm.

Matti Adam, Nigel Geoffrey Kooreman, Ann Jagger, Markus U Wagenhäuser, Dennis Mehrkens, Yongming Wang, Yosuke Kayama, Kensuke Toyama, Uwe Raaz, Isabel N Schellinger and 7 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. The Role of miR-501-3p in Abdominal Aortic Aneurysm Progression: A Pilot Study.Journal of cardiovascular translational research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Matti AdamFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Nigel Geoffrey KooremanFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Ann JaggerFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Markus U WagenhäuserFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Dennis MehrkensDepartment of Cardiovascular Medicine, Cologne Cardiovascular Research Center, University of Cologne, University Heart Center, Germany (M.A., D.M., S.B.).
Yongming WangFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Yosuke KayamaFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Kensuke ToyamaFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Uwe RaazFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Isabel N SchellingerFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Lars MaegdefesselFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Joshua M SpinFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Jaap F HammingDepartment of Vascular Surgery, Leiden University Medical Center, The Netherlands (N.G.K., J.F.H., P.H.A.Q.).
Paul H A QuaxDepartment of Vascular Surgery, Leiden University Medical Center, The Netherlands (N.G.K., J.F.H., P.H.A.Q.).
Stephan BaldusDepartment of Cardiovascular Medicine, Cologne Cardiovascular Research Center, University of Cologne, University Heart Center, Germany (M.A., D.M., S.B.).
Joseph C WuFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Philip S TsaoFrom the Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University School of Medicine, CA (M.A., N.G.K., A.J., M.U.W., Y.W., YK., K.T., U.R., I.N.S., L.M., J.M.S., J.C.W., P.S.T.).
Stanford University · USUniversity of Cologne · DECardiovascular Institute of the South · USLeiden University Medical Center · NLVA Palo Alto Health Care System · USUniversity of Göttingen · DE

Funding

Molecular Imaging of Targeted Cardiac Gene TherapyR01HL093172 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2009 to 2015
$2.7M
Re-Education of the Immune System for hES Cell ToleranceR01AI085575 · NIAID · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2009 to 2013
$2.0M
Insulin Resistance, Vascular Stiffness, and HypertensionR01HL105299 · NHLBI · STANFORD UNIVERSITY · PI TSAO, PHILIP S · 2010 to 2013
$1.6M
MicroRNA Regulation of Nicotine Accelerated AAAsR01HL122939 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI TSAO, PHILIP S · 2014 to 2017
$1.4M
Effects of Inhaled Nicotine on Vascular miR-24 Activity and AAA FormationR56HL135654 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI TSAO, PHILIP S · 2017 to 2017
$300k
Regulatory Role of MicroRNAs in Aging-related Abdominal Aortic Aneurysm DiseaseI01BX002641 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI TSAO, PHILIP S · 2015 to 2019
–
BLRD VA I01 BX002641NHLBI NIH HHS R01 HL093172NHLBI NIH HHS R01 HL105299NHLBI NIH HHS R01 HL122939NHLBI NIH HHS R56 HL135654NIAID NIH HHS R01 AI085575
6 · The paper itself

Abstract

Objective- Recruitment of immunologic competent cells to the vessel wall is a crucial step in formation of abdominal aortic aneurysms (AAA). Innate immunity effectors (eg, macrophages), as well as mediators of adaptive immunity (eg, T cells), orchestrate a local vascular inflammatory response. IL-10 (interleukin-10) is an immune-regulatory cytokine with a crucial role in suppression of inflammatory processes. We hypothesized that an increase in systemic IL-10-levels would mitigate AAA progression. Approach and Results- Using a single intravenous injection protocol, we transfected an IL-10 transcribing nonimmunogenic minicircle vector into the Ang II (angiotensin II)-ApoE

Indexed as

Genetic VectorsGene Transfer TechniquesAngiotensin IIAnimalsAorta, AbdominalAortic Aneurysm, AbdominalAortic DissectionCells, CulturedDilatation, PathologicDisease Models, AnimalGenetic TherapyInflammation MediatorsInterleukin-10Macrophage ActivationMacrophagesMaleAngiotensin IIIL10 protein, mouseInflammation MediatorsInterleukin-10aneurysmcytokinesinterleukinmacrophagesmannose receptortransfection

Identifiers

PMID29880489
PMCPMC6652227
OpenAlexW2807090621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.